# ScoreItem: Claudica√ß√£o

**ID:** `019bf31d-2ef0-7193-b496-afe7ce51ed91`
**FullName:** Claudica√ß√£o (Hist√≥rico de doen√ßas - Hist√≥rico de sa√∫de (Questionar ativamente sobre doen√ßas/sintomas - passado ou atual): - Segmentos apendiculares)

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 15 artigos
- Avg Similarity: 0.555

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7193-b496-afe7ce51ed91`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7193-b496-afe7ce51ed91",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Claudica√ß√£o (Hist√≥rico de doen√ßas - Hist√≥rico de sa√∫de (Questionar ativamente sobre doen√ßas/sintomas - passado ou atual): - Segmentos apendiculares)

**30 chunks de 15 artigos (avg similarity: 0.555)**

### Chunk 1/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.676

istanceinpeo-
plewithlegpainfromintermittentclaudicationwhowereconsideredtobeÔ¨Åtforexerciseintervention.32Pedersen&Saltin
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

Thiswasobtainedwithoutanydemonstrableeffectonthepatients‚Äôanklebloodpressuremeasurements.
Theresultswerenotconclusiveformortalityand
amputation.Inacontrolledstudy,physicaltrainingwascom-paredwithpercutaneoustransluminalangioplasty(PTA)andtheÔ¨ÅndingwasthattherewasnosigniÔ¨Å-cantdifferenceafter6months(Creasyetal.,1990).

---

### Chunk 2/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** introduction | **Similarity:** 0.653

ischemiaatlowexertion(<2METSor50W)ÔøΩAcuteillnessorfeverÔøΩRecentthromboembolismÔøΩActivepericarditisormyocarditisÔøΩModerate/difÔ¨ÅcultaorticstenosisÔøΩValveinsufÔ¨ÅciencyrequiringsurgeryÔøΩAMIwithinthepreceding3weeksÔøΩNewlyoccurringatrialÔ¨ÅbrillationIntermittentclaudicationBackgroundArterialinsufÔ¨Åciencyinthelowerlimbs(lowerlimbischemia,legischemia)isachronicobstructivedis-
easeintheaortabelowtheoutletoftherenalarter-
ies,iliacarteryandthearteriesinthelowerlimbs
probablycausedbyatherosclerosis.Itisestimated
thatatleast4%ofallpeopleabovetheageof65
haveperipheralarteriosclerosis,whichin50%ofcasescausesintermittentpain(intermittentclaudica-tion).Aminorityofpatientsexperiencetheprogres-
sionofperipheralarteriosclerosis,whichresultsin
painwhileatrestandulcerations.Owingtothereal-
izationthatmedicaltreatmentofthediseasehaslimitedefÔ¨Åcacy,theinternationalconsensustodayisthatphysicaltrainingisakeyfactorinthetreatment
ofpatientswithintermittentclaudication(TASC,
2000).Astheintermittentcla

---

### Chunk 3/30
**Article:** 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (2017)
**Journal:** Journal of the American College of Cardiology
**Section:** abstract | **Similarity:** 0.650

This guideline provides recommendations for the diagnosis and management of patients with lower extremity peripheral artery disease (PAD). It covers claudication assessment, ankle-brachial index testing, exercise therapy, pharmacological management, and revascularization criteria. The guideline emphasizes risk factor modification and functional status improvement.

---

### Chunk 4/30
**Article:** The Evaluation of Lower Extremity Arterial Disease: A Clinical Review (2017)
**Journal:** JAMA
**Section:** abstract | **Similarity:** 0.627

Lower extremity peripheral artery disease (PAD) affects approximately 8.5 million people in the United States and more than 200 million worldwide. PAD is associated with increased risk of cardiovascular morbidity and mortality and decreased functional capacity and quality of life. This review examines the epidemiology, diagnosis, and clinical evaluation of lower extremity PAD, including use of the ankle-brachial index (ABI), exercise testing, and advanced imaging modalities. The evaluation begins with careful history and physical examination, focusing on symptoms of claudication, rest pain, and tissue loss.

---

### Chunk 5/30
**Article:** Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia (2019)
**Journal:** Journal of Vascular Surgery
**Section:** abstract | **Similarity:** 0.614

Comprehensive global guidelines for chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease. Covers assessment, revascularization strategies, wound care, and amputation prevention. Emphasizes multidisciplinary care and the importance of early intervention to prevent progression from claudication to CLTI.

---

### Chunk 6/30
**Article:** Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018 (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.611

easePeripheral artery diseasePeripheralartery diseasePeripheral artery diseasePeripheral artery diseasePeripheral artery disease
Inallcases,acurrentguidelinedocumentiscomparedwithitspredecessorcoveringthesamediseaseortopicarea.ACC/AHAindicatesAmericanCollege
ofCardiology/AmericanHeartAssociation;CVD,cardiovasculardisease;ESC,EuropeanSocietyofCardiology;LOE,levelofevidence;NSTE-ACS,acutecoronarysyndromewithoutST-segmentelevation;STEMI,ST-segment
elevationmyocardialinfarction.
LevelsofEvidenceSupportingACC/AHAandESCGuidelines,2008-2018OriginalInvestigationResearchjama.com(Reprinted)JAMAMarch19,2019Volume321,Number111073¬©2019AmericanMedicalAssociation.Allrightsreserved.
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

documentswas(	th-	thpercentiles,.-.),com-paredwith
(	th-	thpercentiles,.

---

### Chunk 7/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.585

olledstudydesign,butreportedthattheeffectofPTAwasminimallybetterthantraining,althoughPTAinvolvedtheriskofserioussideeffects.Arandomizedstudycomparedtheeffectof(a)physicalexercisealone,(b)surgery,and(c)physical
exercise+surgery.Allgroupsachievedthesameeffectonwalkingdistance,butthereweresideeffects
in18%ofthepatientswhounderwentsurgery
(Lundgrenetal.,1989).Anotherrandomizedstudycomparedtheeffectofphysicaltrainingandantithrombotictherapy
(Mannarinoetal.,1991).AsigniÔ¨Åcantlylarger
improvementinwalkingdistancewasrecordedfor
thegroupthatexercised(86%)comparedwiththe
groupthatreceivedmedication(38%).Ameta-ana-
lysisfoundthattrainingprogramsweresubstantially
cheaperandinvolvedfewerrisksthaneithersurgeryorPTA(deVriesetal.,2002).Furthermore,ameta-analysishasshownthatqualityoflifeincreaseswith
walkingdistance(Regensteineretal.,2002).Arecentreviewanalyzedthesafetyofsupervisedexercisetraininginpatientswithintermittentclaudi-
cation(Gommansetal.,2015).Therehasbeencon-
cernregardingthesafetyofperfo

---

### Chunk 8/30
**Article:** Dislipdemia (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.561

quais ~250 mil ocorrem antes dos 60 anos.
- Brasil: 410 mil mortes/ano por DCV; 14 milh√µes com alguma DCV; 36% dos √≥bitos ‚â•55 anos decorrem de doen√ßa cardio-circulat√≥ria.
- Fisiopatologia: fluxo arterial torna-se turbilhonado ~50% de estenose, aumentando estresse de parede e risco de ruptura de placa.
**Achados Adicionais**
- LDL alvo em baixo risco: diretriz sugere <130 mg/dL (por vezes <100), mas o n√∫mero isolado n√£o determina benef√≠cio sem DCV pr√©via e sem avalia√ß√£o de part√≠culas/c√°lcio.
- LDL basal em estudo: 190 mg/dL; colesterol total 275 e HDL 31, ilustrando perfis iniciais elevados; em pacientes com c√°lcio zero, LDL >240 n√£o alterou mortalidade/infarto com estatina.

---

### Chunk 9/30
**Article:** Differentiating Vascular From Neurogenic Claudication: A Systematic Review (2021)
**Journal:** JBJS Reviews
**Section:** abstract | **Similarity:** 0.557

This systematic review examines clinical features, imaging findings, and diagnostic tests to differentiate vascular claudication from neurogenic claudication due to spinal stenosis. Key discriminators include pain pattern, positional relief, peripheral pulses, and ankle-brachial index. The review provides evidence-based diagnostic algorithms for clinical practice.

---

### Chunk 10/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** introduction | **Similarity:** 0.556

hereasonwhywalk-
ingexerciseispreferable.Ifbikeexerciseischosen,thepatientmustbeinstructedtopedalusingthe33Exerciseasmedicine‚Äìevidenceforprescribingexercise
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

frontofthefootandthesametrainingprinciplesapplyasforwalking.ContraindicationsTherearenogeneralcontraindications.Supervised
exercisetrainingcansafelybeprescribedinpatients
withintermittentclaudicationbecauseanexceed-inglylowall-causecomplicationrateisfound.Rou-tinecardiacscreeningbeforecommencingexercise
trainingisnotrequired.PulmonarydiseasesChronicobstructivepulmonarydiseaseBackgroundChronicobstructivepulmonarydisease(COPD)is
characterizedbyanirreversibledecreaseinlungfunction.Advanced-stageCOPDisalongandpain-fulprocessofgraduallyincreasingandultimately
disablingbreathlessnessasthemainsymptom.

---

### Chunk 11/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.549

thmaImmunol2002:
89:226‚Äì235.TarumiN,IwasakaT,TakahashiN,SugiuraT,MoritaY,SumimotoT,NishiueT,InadaM.Leftventricular
diastolicÔ¨Ållingpropertiesindiabetic
patientsduringisometricexercise.Cardiology1993:83:316‚Äì323.TASC.Managementofperipheralarterialdisease.EurJVascEndovascSurg2000:19:S1‚ÄìS250.TaylorCB,JatulisDE,WinklebyMA,RockhillBJ,KraemerHC.Effectsof
life-styleonbodymassindexchange.Epidemiology1994:5:599‚Äì603.TaylorRS,BrownA,EbrahimS,JolliffeJ,NooraniH,ReesK,
SkidmoreB,StoneJA,ThompsonDR,OldridgeN.Exercise-basedrehabilitationforpatientswith
coronaryheartdisease:systematicreviewandmeta-analysisofrandomizedcontrolledtrials.AmJ
Med2004:116:682‚Äì692.TaylorRS,SagarVA,DaviesEJ,BriscoeS,CoatsAJ,DalalH,LoughF,ReesK,SinghS.Exercise-based
rehabilitationforheartfailure.

---

### Chunk 12/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.548

dade, inatividade f√≠sica, press√£o arterial e dislipidemia.
- A inflama√ß√£o √© indicada por marcadores como a Prote√≠na C-Reativa (PCR), onde um valor de 5 j√° √© considerado elevado, e a Interleucina 6 (exemplo de paciente com 8.45).
- A resposta anti-inflamat√≥ria √© medida pela Interleucina 10, com um valor de corte de 3,5 (abaixo disso √© um risco) e um exemplo de paciente com 6.44.
- A sa√∫de do endot√©lio √© avaliada pelo √≥xido n√≠trico, que deve estar em 8.8; um paciente com 4.8 j√° apresenta disfun√ß√£o sist√™mica.
- A LDL oxidada √© um marcador cr√≠tico, com um limite saud√°vel de 133, enquanto pacientes de alto risco podem apresentar valores extremos, como 1000.
**Achados Adicionais**
- Existem cinco par√¢metros cl√°ssicos para definir a s√≠ndrome metab√≥lica.
- O alvo de LDL para pacientes de alto risco, segundo as diretrizes atuais, √© de 50.

---

### Chunk 13/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.547

ase.
LancetNeurol2006:5:525‚Äì535.deVriesSO,VisserK,deVriesJA,WongJB,DonaldsonMC,HuninkMG.Intermittentclaudication:cost-
effectivenessofrevascularization
versusexercisetherapy.Radiology2002:222:25‚Äì36.DelaF,HandbergA,MikinesKJ,VintenJ,GalboH.GLUT4andinsulinreceptorbindingandkinaseactivityintrainedhumanmuscle.J
Physiol1993:469:615‚Äì624.DelaF,LarsenJJ,MikinesKJ,PlougT,PetersenLN,GalboH.Insulin-stimulatedmuscleglucoseclearance
inpatientswithNIDDM.Effectsof
one-leggedphysicaltraining.Diabetes1995:44:1010‚Äì1020.DelaF,PlougT,HandbergA,PetersenLN,LarsenJJ,MikinesKJ,GalboH.PhysicaltrainingincreasesmuscleGLUT4proteinandmRNAinpatientswithNIDDM.Diabetes1994:43:862‚Äì865.DemopoulosL,BijouR,FergusI,JonesM,StromJ,LeJemtelTH.Exercisetraininginpatientswith
severecongestiveheart
failure:enhancingpeakaerobiccapacitywhileminimizingtheincreaseinventricularwall
stress.JAmCollCardiol1997:29:
597‚Äì603.DePueJD,ClarkMM,RuggieroL,MedeirosML,PeraVJr.

---

### Chunk 14/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.543

e estilo de vida e suporte nutricional.
- [ ] 8. Incluir dosagem de TNF-Œ±, IL-6, IL-10 e PCR para avalia√ß√£o inflamat√≥ria/anti-inflamat√≥ria; solicitar Lp(a), NO, fosfolipase A2, LDL oxidado e, quando poss√≠vel, subfra√ß√µes de LDL.
- [ ] 9. Avaliar criteriosamente o uso de estatina p√≥s-angioplastia (benef√≠cio anti-inflamat√≥rio local) com doses adequadas e tempo limitado; evitar uso indiscriminado em preven√ß√£o prim√°ria.
- [ ] 10. Reexaminar protocolos de UTI que aplicam estatinas automaticamente, incorporando avalia√ß√£o de risco de del√≠rio e monitoriza√ß√£o metab√≥lica (glicemia, resist√™ncia √† insulina, CoQ10).
- [ ] 11. Revisar meta-an√°lises e evid√™ncias sobre hip√≥tese lip√≠dica, distinguindo risco relativo de risco absoluto na tomada de decis√£o.
- [ ] 12. Educar pacientes sobre inflama√ß√£o cr√¥nica subcl√≠nica e sua rela√ß√£o com DCV, visando melhorar compreens√£o e ades√£o.

---

### Chunk 15/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIV (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.541

- [ ] 2. Para pacientes com s√≠ndrome metab√≥lica, considerar estrat√©gia Mediterr√¢nea organizada; preferir vers√£o com restri√ß√£o cal√≥rica combinada com atividade f√≠sica, monitorando resultados aos 6 e 12 meses.
- [ ] 3. Solicitar perfil lip√≠dico ampliado em casos selecionados: HDL, triglicer√≠deos, insulina, PCR, LDL oxidado e, quando indicado, subfracionamento de LDL; evitar decis√µes baseadas apenas em LDL total.
- [ ] 4. Planejar exames de risco cardiovascular conforme necessidade: score de c√°lcio coronariano e angiotomografia de coron√°rias (incluindo avalia√ß√£o de placas moles) quando o contexto cl√≠nico justificar.
- [ ] 5. Revisar e atualizar protocolos internos sobre √°lcool: remover recomenda√ß√µes de consumo ‚Äúcardioprotetor‚Äù; educar pacientes sobre riscos de c√¢ncer e piora do sono; avaliar predisposi√ß√£o/sensibilidade individual.
- [ ] 6.

---

### Chunk 16/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.540

atmedicaltreatmentofthediseasehaslimitedefÔ¨Åcacy,theinternationalconsensustodayisthatphysicaltrainingisakeyfactorinthetreatment
ofpatientswithintermittentclaudication(TASC,
2000).Astheintermittentclaudicationbecomes
moresevere,functionleveldecreasesandqualityof
lifebecomesaffected.Increasingpainwhenwalkingandtheconsequentfearofmovinggraduallycausesthepatienttobecomestaticandsociallyisolated.In
thelongterm,thisleadstodeteriorationofÔ¨Åtness
andtheprogressionofarteriosclerosis,reducedmus-
clestrengthandmuscleatrophy,trappingthepatient
inaviciouscircleofpoorÔ¨Åtness,pain,andsocialiso-
lation.Physicalactivitycanbeusedtointerruptthis
viciouscircleanddirectlyaffectthepathogenesisofthediseasebyincreasingÔ¨Åtnessandmusclestrength,changingpainthresholdsandtheperceptionofpain,
allayingfear,andpreventingdiseaseprogression.Evidence-basedphysicaltrainingThereissolidevidencedemonstratingthebeneÔ¨Åcial
effectofphysicaltrainingonpatientswithintermit-
tentclaudication.ACochraneReviewsfrom2014
(Laneeta

---

### Chunk 17/30
**Article:** Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018 (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.539

ceGuidelinesfortheManagementof
PatientsWithPeripheralArterialDisease(Lower
Extremity,Renal,Mesenteric,andAbdominal
Aortic).Circulation.2006;113(11):e463-e654.74.StoneNJ,RobinsonJG,LichtensteinAH,etal;AmericanCollegeofCardiology/AmericanHeart
AssociationTaskForceonPracticeGuidelines.2013
ACC/AHAGuidelineontheTreatmentofBlood
CholesteroltoReduceAtherosclerotic
CardiovascularRiskinAdults.JAmCollCardiol.2014;63(25,ptB):2889-2934.doi:10.1016/j.jacc.2013.11.00275.WindeckerS,KolhP,AlfonsoF,etal.2014ESC/EACTSGuidelinesonMyocardial
Revascularization:theTaskForceonMyocardial
RevascularizationoftheEuropeanSocietyofCardiology(ESC)andtheEuropeanAssociationforCardio-ThoracicSurgery(EACTS)developedwith
thespecialcontributionoftheEuropean
AssociationofPercutaneousCardiovascular
Interventions(EAPCI).EurHeartJ.2014;35(37):2541-2619.doi:10.1093/eurheartj/ehu27876.ManciaG,FagardR,NarkiewiczK,etal.2013ESH/ESCGuidelinesfortheManagementofArterial
Hypertension:theTaskForcefortheManagement
ofArterialHypertensi

---

### Chunk 18/30
**Article:** Supervised Exercise Therapy Versus Non-Supervised Exercise Therapy for Intermittent Claudication (2018)
**Journal:** Cochrane Database of Systematic Reviews
**Section:** abstract | **Similarity:** 0.531

This Cochrane systematic review demonstrates that supervised exercise therapy provides superior outcomes compared to non-supervised exercise for intermittent claudication. Supervised programs improve maximum walking distance, quality of life, and functional capacity. The review supports supervised exercise as first-line therapy for claudication.

---

### Chunk 19/30
**Article:** Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018 (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.531

table
Angina:areportoftheAmericanCollegeof
Cardiology/AmericanHeartAssociationTaskForce
onPracticeGuidelines(CommitteeonManagement
ofPatientsWithChronicStableAngina).JAmCollCardiol.1999;33(7):2092-2197.doi:10.1016/S0735-1097(99)00150-373.HirschAT,HaskalZJ,HertzerNR,etal;AmericanAssociationforVascularSurgery;Society
forVascularSurgery;SocietyforCardiovascular
AngiographyandInterventions;SocietyforVascular
MedicineandBiology;SocietyofInterventional
Radiology;ACC/AHATaskForceonPractice
GuidelinesWritingCommitteetoDevelop
GuidelinesfortheManagementofPatientsWith
PeripheralArterialDisease;AmericanAssociationof
CardiovascularandPulmonaryRehabilitation;
NationalHeart,Lung,andBloodInstitute;Society
forVascularNursing;TransAtlanticInter-Society
Consensus;VascularDiseaseFoundation.ACC/AHA
2005PracticeGuidelinesfortheManagementof
PatientsWithPeripheralArterialDisease(Lower
Extremity,Renal,Mesenteric,andAbdominal
Aortic).Circulation.2006;113(11):e463-e654.74.StoneNJ,RobinsonJG,LichtensteinAH,etal;

---

### Chunk 20/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.526

tematicreview.Arch
InternMed2010:170:321‚Äì331.HiattWR,RegensteinerJG,HargartenME,WolfelEE,BrassEP.BeneÔ¨Åtofexerciseconditioning
forpatientswithperipheralarterial
disease.Circulation1990:81:602‚Äì609.HigashiY,SasakiS,KurisuS,YoshimizuA,SasakiN,Matsuura
H,KajiyamaG,OshimaT.Regularaerobicexerciseaugmentsendothelium-dependentvascular
relaxationinnormotensiveaswellashypertensivesubjects:roleofendothelium-derivednitricoxide.

---

### Chunk 21/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.525

ardiovasculardiseaseandantithrombotictherapy.EurHeartJ.2013;34:1708‚Äì1713,1713a‚Äì1713b.697.JamesS,BudajA,AylwardP,etal.Ticagrelorversusclopidogrelinacutecoronarysyndromesinrelationtorenalfunction:resultsfromthePlateletInhibitionandPatientOutcomes(PLATO)trial.Circulation.2010;122:1056‚Äì1067.698.HerringtonWG,StaplinN.InpatientswithcoronarydiseaseandCKD,
addinganinvasivestrategytoMTdidnotimproveoutcomes.AnnInternMed.2020;173:JC16.699.SarnakMJ,AmannK,BangaloreS,etal.Chronickidneydiseaseand
coronaryarterydisease:JACCstate-of-the-artreview.JAmCollCardiol.2019;74:1823‚Äì1838.700.CharytanDM,WallentinL,LagerqvistB,etal.Earlyangiographyin
patientswithchronickidneydisease:acollaborativesystematicreview.ClinJAmSocNephrol.2009;4:1032‚Äì1043.701.HastingsRS,HochmanJS,DzavikV,etal.Effectoflaterevascularization
ofatotallyoccludedcoronaryarteryaftermyocardialinfarctiononmortalityratesinpatientswithrenalimpairment.AmJCardiol.2012;110:954‚Äì960.702.JohnstonN,JernbergT,LagerqvistB,etal.Earlyinvasivetrea

---

### Chunk 22/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.525

iscriminado; meta-an√°lise desafiando causalidade LDL‚ÄìDCV e vieses estat√≠sticos (risco relativo vs. absoluto).
- UTI: alerta para aumento de del√≠rio e evitar protocolos autom√°ticos; decis√£o individualizada.
- Mecanismos pr√≥-diabetes: via HMG-CoA redutase, impacto em GLUT4, receptores de insulina e redu√ß√£o de CoQ10; necessidade de monitoriza√ß√£o e decis√£o compartilhada.
### 11. Avalia√ß√£o cl√≠nica com biomarcadores
- Inflama√ß√£o: TNF-Œ±, IL-6; anti-inflamat√≥rio IL-10 (valores baixos associam maior risco); PCR como marcador de estado inflamat√≥rio.
- Vasculares/endoteliais: Lp(a) (vari√°vel geneticamente), √≥xido n√≠trico (NO) como indicador de sa√∫de endotelial, fosfolipase A2 como componente de placa e risco de ruptura.
- Lip√≠dicos: LDL oxidado e subfra√ß√µes pequenas/densas (maior risco de oxida√ß√£o).
- Integra√ß√£o de marcadores para estratifica√ß√£o e decis√£o terap√™utica al√©m dos seis fatores cl√°ssicos.
### 12.

---

### Chunk 23/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.520

ntingdiseaseprogression.Evidence-basedphysicaltrainingThereissolidevidencedemonstratingthebeneÔ¨Åcial
effectofphysicaltrainingonpatientswithintermit-
tentclaudication.ACochraneReviewsfrom2014
(Laneetal.,2014)included30trials,involvingatotalof1816participantswithstablelegpain.Thefollow-upperiodrangedfrom2weeksto2years.
Thetypesofexercisevariedfromstrengthtrainingto
polestridingandupperorlowerlimbexercises;gen-
erallysupervisedsessionswereatleasttwiceaweek.

---

### Chunk 24/30
**Article:** Emagrecimento - Parte VIII (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.519

elev√¢ncia cl√≠nica.
- Boswellia padronizada entrega mesma efic√°cia com menos c√°psulas, favorecendo ades√£o.
- Suplementos lip√≠dicos devem ser tomados com refei√ß√µes para melhor absor√ß√£o e conforto g√°strico.
### Alavancas cl√≠nicas complementares
Protocolos simples e personalizados maximizam resultados em dor, inflama√ß√£o e emagrecimento.
- Inala√ß√£o direta supera difus√£o ambiental para efeitos terap√™uticos de √≥leos essenciais.
- Beta-cariofileno da copa√≠ba ativa CB2 e favorece analgesia e modula√ß√£o inflamat√≥ria.
- Otimizar vitamina D melhora resist√™ncia insul√≠nica e marcadores inflamat√≥rios, com doses individualizadas por polimorfismos GC/VDR.

---

### Chunk 25/30
**Article:** Dislipdemia (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.518

vida e identificar fatores de risco para inflama√ß√£o e disfun√ß√£o endotelial (dieta, estresse, sedentarismo).
- [ ] 2. Utilizar a calculadora MESA Risk para determinar o risco cardiovascular dos pacientes e considerar a solicita√ß√£o do Escore de C√°lcio Coronariano antes de prescrever estatinas em preven√ß√£o prim√°ria.
- [ ] 3. Ao avaliar o risco cardiovascular, solicitar exames avan√ßados como a rela√ß√£o ApoB/ApoA, subpart√≠culas de lipoprote√≠nas e anti-LDL oxidado para uma an√°lise mais aprofundada.
- [ ] 4. Em pacientes de preven√ß√£o prim√°ria, mesmo com colesterol alto, priorizar mudan√ßas no estilo de vida antes de considerar o uso de estatinas.
- [ ] 5. Reservar o uso de estatinas principalmente para pacientes em preven√ß√£o secund√°ria ou de alt√≠ssimo risco, focando nos seus efeitos pleotr√≥picos.
- [ ] 6.

---

### Chunk 26/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.515

gexercisemeasuredwithatreadmilltest,
whilethereislittleinformationonotherformsof
training.OnestudyfoundbeneÔ¨Åcialeffectsfrom
Nordicwalkingcomparedtoanon-exercisingcon-
trolgroup(Langbeinetal.,2002).Nordicwalking
involveswalkingusingpolesinbothhands,which
partlyprovidesupportandpartlyforcethepatienttomovetheupperbody,increasingoverallexer-tion.Thereislimitedinformationontheimpor-
tanceofwalkingspeedorintensity,butstrong
evidencetosuggestthattheeffectisincreasedif
trainingiscarriedoutuntiltheonsetofischemia
symptoms.Controlledtrialsprovidesome,albeit
limited,evidencethatsupervisedtrainingismore
effectivethanunsupervisedtraining(Regensteineretal.,1996;Bendermacheretal.,2006;Wind&Koelemay,2007;Shalhoubetal.,2009).Theeffect
oftrainingisreinforcedifthepatientquitssmoking
(Jonason&Ringqvist,1987)andtheamountof
trainingisadeterminingfactorinefÔ¨Åcacy(Nicolai
etal.,2010).Physicalactivityshouldpreferablybeintheformofwalkingexercise,whichshouldinitiallybesuper-visedthroughregularvisitstoatherapi

---

### Chunk 27/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.514

t√™ncia √† leptina), atividade f√≠sica regular.
- [ ] 10. Avaliar marcadores de inflama√ß√£o e oxida√ß√£o (PCR, ferritina, fibrinog√™nio, LDL oxidado) para estratifica√ß√£o de risco e monitoramento terap√™utico.
- [ ] 11. Considerar uso de agonistas GLP-1 (ex.: semaglutida) em pacientes com obesidade e/ou DCV para perda de peso e redu√ß√£o de eventos, conforme indica√ß√£o cl√≠nica.
- [ ] 12. Monitorar fun√ß√£o auton√¥mica e sinais de insufici√™ncia card√≠aca diast√≥lica em pacientes com resist√™ncia √† insulina/diabetes, com interven√ß√£o precoce.
- [ ] 13. Educar pacientes sobre rela√ß√£o entre disfun√ß√£o er√©til e risco cardiovascular, estimulando avalia√ß√£o proativa do endot√©lio e fun√ß√£o vascular.

---

## SOAP

Data e Hora: 2025-11-20 20:43:35
Paciente: 
Diagn√≥stico:
## Hist√≥rico de Diagn√≥stico:
1.  **Hist√≥rico M√©dico:** O conte√∫do √© uma palestra m√©dica sobre fatores de risco cardiovascular contempor√¢neos, n√£o uma consulta com um paciente espec√≠fico.
2.

---

### Chunk 28/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** introduction | **Similarity:** 0.509

leadto
ulcersandfracture.Jogging/walkingtreadmill,long
walks/runs,andstepexercisesarenotrecommended,
whilenon-body-bearingphysicalexerciseisrecom-mendable,suchascycling,swimming,androwing.Oneshouldbeawarethatpatientswithauto-nomicneuropathymayhavesevereischemiawith-
outsymptoms(silentischemia).Thesepatients
typicallysufferfromrestingtachycardia,ortho-
statism,andpoorthermoregulation.Thereisadan-
gerofsuddencardiacdeath.Itmaybeadvisableto
consultacardiologistandcarryoutanexerciseECGoramyocardialscintigraphy.Patientsshould24Pedersen&Saltin
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

beinstructedtoavoidphysicalactivityincoldorhottemperaturesandtoensureadequatehydration
duringphysicalactivity.CardiovasculardiseasesCerebralapoplexyBackgroundCerebralapoplexy(stroke,cerebrovascularaccident,
apoplexy)isdeÔ¨ÅnedbyWHOasarapidonsetdisor-
derofbrainfunctionwithsymptomslastingmore
than24horleadingtodeath,andwhere

---

### Chunk 29/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIII (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.509

co da dislipidemia.
- [ ] 2. Analisar criticamente os estudos sobre o Inclisiran (Cibrava), focando na diferen√ßa entre desfechos substitutos (redu√ß√£o de LDL) e desfechos cl√≠nicos duros (mortalidade, infarto, AVC).
- [ ] 3. Utilizar o site `the-nnt.com` para pesquisar o NNT e NNH de outros medicamentos prescritos na pr√°tica cl√≠nica.
- [ ] 4. Refletir sobre a influ√™ncia da ind√∫stria farmac√™utica e dos interesses financeiros na prescri√ß√£o de novos medicamentos.
- [ ] 5. Estudar a diferen√ßa entre risco relativo e risco absoluto para interpretar criticamente os achados de estudos cient√≠ficos.
- [ ] 6. Pesquisar sobre os diferentes tipos de √¥mega-3 (EPA, DHA, ALA) e suas formula√ß√µes para entender como a qualidade do suplemento afeta os resultados.
- [ ] 7. Investigar os exames de subfracionamento de LDL e a rela√ß√£o ApoA/ApoB como ferramentas de avalia√ß√£o de risco cardiovascular mais precisas que o LDL total.
- [ ] 8.

---

### Chunk 30/30
**Article:** Cardiologia IV (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.509

 ria e Mortalidade Geral:**
    *   Uma meta-an√°lise com mais de 65 mil participantes concluiu que o uso de estatinas √© ineficaz para a redu√ß√£o da mortalidade por todas as causas na preven√ß√£o prim√°ria.
    *   Embora ineficaz a n√≠vel populacional, reconhece-se que indiv√≠duos espec√≠ficos podem se beneficiar, sendo o desafio identific√°-los.
*   **Efeitos Adversos e sua Incid√™ncia (NNT vs. NND):**
    *   **NNT (N√∫mero Necess√°rio para Tratar):** Para prevenir 1 infarto (n√£o fatal), √© preciso tratar 104 pessoas; para prevenir 1 AVC, 154 pessoas.
    *   **NND (N√∫mero Necess√°rio para Causar Dano):** 1 em cada 50 pessoas tratadas desenvolver√° diabetes; 1 em cada 10 sofrer√° danos musculares.
    *   Outros efeitos incluem protein√∫ria e hepatotoxicidade. As dores musculares podem impedir a pr√°tica de exerc√≠cios, que por si s√≥ s√£o mais eficazes na preven√ß√£o.

---

